|
Postponed - Date To Be Announced
Join colleagues for breakfast and a discussion led by Debbie Snyder, Vice President, Business Development, TGen Drug Development. Details to be announced About the Speaker
Debbie Snyder, MBA, RT, CLS (NCA) Vice President, Business Development, TGen Drug Development
Ms. Snyder is responsible for day-to-day activities related to the integrated business operations of a not-for-profit service provider organization. As an affiliate of the Translational Genomics Research Institute (TGen), TGen Drug Development Services is focused on innovation and acceleration in the early stage development of oncology experimental agents. Debbie has been with TGen for over six years building infrastructure, pricing models and partners to share in this translational mission.
Ms. Snyder possesses over 20 years experience in the life sciences field. She contributes a broad-ranging academic and professional grounding in immunology, hematology, microbiology and biochemistry with a Medical Laboratory Science background, coupled with an Executive Master of Business Administration degree from Simon Fraser University, Vancouver, Canada in 2002.
|